(Adnkronos) – Michelino De Laurentiis, director of the Breast and Thoraco-Pulmonary Oncology Department, Pascale Institute of Naples: “The results obtained with ribociclib in addition to standard hormonal therapy are important. Our goal remains the definitive recovery of the patients”.